Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action

被引：0
作者：
Lamia Y. Haque
Paola Zuluaga
Robert Muga
Daniel Fuster
机构：
[1] Digestive Diseases,Department of Medicine
[2] & Program in Addiction Medicine,Department of Internal Medicine, Addiction Unit
[3] Yale School of Medicine,undefined
[4] Hospital Universitari Germans Trias i Pujol,undefined
[5] Universitat Autònoma de Barcelona,undefined
来源：
Addiction Science & Clinical Practice | / 19卷
关键词：
Alcohol use disorder; Alcohol-associated liver disease; Treatment; Addiction medicine; Hepatology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Alcohol-associated liver disease is currently the leading cause of liver transplantation and liver deaths both in Europe and the United States. Efficacious treatments exist for alcohol use disorder, but they are seldomly prescribed for patients who need them. Besides, the presence of liver cirrhosis can complicate pharmacological treatment choices. In this review, we discuss established and innovative treatment strategies to treat unhealthy alcohol use in patients with alcohol-associated liver disease. We also describe the experience of our own institutions, Hospital Universitari Germans Trias i Pujol in Badalona (Spain) and Yale-New Haven Health and Yale Medicine (Connecticut. United States of America).
引用
收藏
相关论文
共 322 条
[21]  
Caputo F(2009)Primary care validation of a single-question alcohol screening test J Gen Intern Med 66 1464-2095
[22]  
Domenicali M(2017)Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study Hepatology 5 2080-27
[23]  
Bernardi M(2021)Associations Between Alcohol Use and Liver-Related Outcomes in a Large National Cohort of Patients With Cirrhosis Hepatol Commun 91 20-312
[24]  
Asrani SK(2018)Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis J Subst Abuse Treat 57 306-2092
[25]  
Mellinger J(2012)Excessive alcohol consumption after liver transplantation impacts on long-term survival, whatever the primary indication J Hepatol 71 2080-1997
[26]  
Arab JP(2020)Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis Hepatology 5 1953-1430
[27]  
Shah VH(2022)Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder JAMA Netw open 384 1421-1835
[28]  
Crabb DW(2022)Psychotherapy for Alcohol Use Disorder Is Associated With Reduced Risk of Incident Alcohol-Associated Liver Disease Clin Gastroenterol Hepatol 49 1797-911
[29]  
Im GY(2014)Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis Lancet 77 906-642
[30]  
Szabo G(2019)Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long-term follow-up study of 1317 patients Aliment Pharmacol Ther 45 636-630
12345678910